NCT02507570 2019-03-19Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone MetastasisCarolina Research Professionals, LLCPhase 2 Completed40 enrolled